NOVO NORDISK LIMITED
Get an alert when NOVO NORDISK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£70m
+26.7% highest in 3 filed years
Employees
519
+2.6% highest in 3 filed years
Profit before tax
£28m
+9.3% highest in 3 filed years
Watch the reel
Our short-form breakdown of NOVO NORDISK LIMITED's latest filing
Novo Nordisk's UK arm saw a 14% revenue jump, but a heavier tax bill dragged down the bottom line. 📉💉
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £549,670,000 | £558,475,000 | £636,797,000 | +14% | |
| Operating profit | £20,334,000 | £23,231,000 | £26,133,000 | +12.5% | |
| Profit before tax | £24,635,000 | £26,042,000 | £28,461,000 | +9.3% | |
| Net profit | £18,169,000 | £19,193,000 | £15,793,000 | -17.7% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £37,989,000 | £58,868,000 | £81,436,000 | +38.3% | |
| Net assets | £35,131,000 | £55,587,000 | £70,428,000 | +26.7% | |
| Equity | £35,131,000 | £55,587,000 | £70,428,000 | +26.7% | |
| Average employees | 483 | 506 | 519 | +2.6% | |
| Wages | £45,278,000 | £49,509,000 | £53,601,000 | +8.3% | |
| Directors' remuneration | £785,000 | £816,000 | £805,000 | -1.3% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 3.7% | 4.2% | 4.1% | |
| Net margin | 3.3% | 3.4% | 2.5% | |
| Return on capital employed | 53.5% | 39.5% | 32.1% | |
| Gearing (liabilities / total assets) | 78.0% | 75.2% | — | |
| Current ratio | 1.28x | 1.33x | 1.36x | |
| Interest cover | — | — | 20.82x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- NOVO NORDISK LIMITED 2000-11-14 → present
- NOVO NORDISK PHARMACEUTICALS LIMITED 1990-01-02 → 2000-11-14
- NORDISK-UK LIMITED 1980-12-31 → 1990-01-02
- NORDISK DIAGNOSTICS LIMITED 1973-06-18 → 1980-12-31
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company has prepared a cash flow forecast for a minimum of 12 months from the date of signing of the Directors' report. Having examined the current status of the Company's principal contracts and likely developments in the foreseeable future, the directors consider that the Company will be able to settle its liabilities as they fall due and accordingly the financial statements have been prepared on a going concern basis.”
Significant events
- “Novo Nordisk Limited continued to perform strongly against a backdrop of disruption due to product shortages across the pharmaceutical industry. This would not have been possible without the resilience and collaborative spirit shown by colleagues across the organisation.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 28 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MCDERMID, Jocelyn | Secretary | 2024-11-27 | — | — |
| BAILEY, Nicholas James | Director | 2008-09-29 | Apr 1973 | British |
| LARSEN, Jonas Emil Kongshoj | Director | 2022-11-22 | Sep 1975 | Danish |
| NIELSEN, Thomas Rask | Director | 2024-04-30 | Jul 1970 | Danish |
| TUNA, Sebnem Avsar | Director | 2025-02-06 | Sep 1971 | Turkish |
Show 28 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAILEY, Nicholas James | Secretary | 2011-02-16 | 2012-05-01 |
| BROWN, Stephen Lawrence | Secretary | 1992-09-07 | 1999-10-14 |
| EDWARDS, David | Secretary | — | 1992-09-07 |
| LLOYD-GOODWIN, Wendy Helen | Secretary | 2009-05-18 | 2011-02-16 |
| O'FLYNN, Matthew | Secretary | 2012-05-01 | 2024-10-15 |
| ROBERTS, Sandra | Secretary | 1999-10-15 | 2009-05-18 |
| AYLWARD, Gordon Charles | Director | — | 1995-02-13 |
| BARRY, Nicholas | Director | 2008-03-18 | 2012-09-28 |
| BIRCH, Viggo Ludvig | Director | 2001-09-01 | 2012-04-30 |
| EHRLICH, Klaus | Director | 2002-03-12 | 2005-07-14 |
| EVANS, Hywel | Director | 1995-02-13 | 1997-12-01 |
| GRUHN, Jerzy Roman | Director | 2013-08-01 | 2016-11-17 |
| HAAGEN, Tomas | Director | 2018-11-20 | 2024-04-29 |
| HELMICH, Pal | Director | — | 2002-02-20 |
| JELERT, Soren | Director | 2005-09-08 | 2008-06-30 |
| JORDAN, Doxie Alphonza | Director | 2014-11-10 | 2018-04-06 |
| JORGENSEN, Lars Almblom | Director | — | 1993-06-23 |
| KIER, Frederik | Director | 2020-07-28 | 2022-11-18 |
| MEEUS, Peter Paul Armand | Director | 2012-05-01 | 2014-08-21 |
| NEILSEN, Henrik Juuel | Director | 2003-01-23 | 2005-08-05 |
| RAMSBY, Ole Falvig | Director | 1997-07-25 | 2018-11-20 |
| REGAN, Matt Joseph | Director | 2017-11-16 | 2020-07-03 |
| SAHOTA, Pinder | Director | 2018-11-20 | 2024-12-31 |
| SAUNDERS, Ingelise | Director | 1997-12-01 | 2001-08-31 |
| SCHULTZ, Kare | Director | 2005-04-22 | 2008-03-17 |
| SOETERS, Martinus Hermanus | Director | 2008-03-18 | 2013-08-01 |
| SORENSEN, Jakob | Director | 1996-04-24 | 1997-04-30 |
| SORENSEN, Mads Ravn | Director | — | 1996-04-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novo Nordisk Holding Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 191 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-11 | AA | accounts | Accounts with accounts type full | |
| 2026-07-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-06-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-19 | AA | accounts | Accounts with accounts type full | |
| 2025-04-30 | CH01 | officers | Change person director company with change date | |
| 2025-02-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-03 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-10-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-27 | AD02 | address | Change sail address company with old address new address | |
| 2024-06-25 | AA | accounts | Accounts with accounts type full | |
| 2024-05-01 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-28 | AA | accounts | Accounts with accounts type full | |
| 2023-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-06 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-06 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-07 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.